For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit: https://www.mycme.com/courses/strategies-and-real-world-impact-of-the-stimulant-crisis-10220 Summary The stimulant medication shortage has introduced new challenges in managing ADHD, affecting both patients’ access to essential treatments and clinicians’ ability to provide consistent care. In this PsychTalk podcast/webcast episode, Drs. Gregory Mattingly and Roger McIntyre explore the impact of these shortages, particularly on cognitive functioning, treatment continuity, and daily life for individuals with ADHD. Their discussion also examines stimulant misuse and diversion, looking at trends in medication sourcing, formulations most susceptible to abuse, and strategies to reduce the risk of misuse. By the end of the episode, learners will be equipped with timely insights and real-world tools to optimize ADHD management amid evolving supply and safety challenges. This podcast was recorded and is being used with permission of the presenters. Learning Objectives At the conclusion of this activity, participants should be better able to: Describe the impact of stimulant shortages on individuals with ADHD Incorporate best-practice clinical strategies to minimize the risk of stimulant misuse in the treatment of ADHD This activity is accredited for CME/CE Credit This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the ACCME to provide continuing medical education for physicians. The National Association for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of the National Association for Continuing Education (NACE) and GlobalHealthXchange. NACE is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider number 121222. This activity is approved for 0.50 contact hours (which includes 0.50 hours of pharmacology). For additional information about the accreditation of this program, please contact NACE at
[email protected] . Summary of Individual Disclosures Please review faculty and planner disclosures here. Disclosure of Commercial Support This activity is not supported by an educational grant. Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
